How much does Denosumab cost?

Denosumab (Denosumab) is a drug used to treat bone-related diseases, mainly for the management of osteoporosis and cancer bone metastases. This drug has a specific mechanism of action, as it is a monoclonal antibody that interferes with the bone resorption process, thereby increasing bone density and reducing the risk of fractures.

The generic drug Desosomet is already on the market in China and has been included in medical insurance. Patients can purchase it domestically at a price of about 1,600 yuan. Please consult the local hospital pharmacy or medical insurance bureau for specific prices and reimbursement policies. There are only denosumab original drugs available abroad, mainly the Turkish version of the American Amgen original drug. The price is about 1,300 yuan, and the ingredients and efficacy are consistent with the domestic original drug.

Denosumab increases bone density by inhibiting the activity of bone cells (osteoclasts) during bone resorption. This is especially important for those with osteoporosis, who have reduced bone density and are more susceptible to fractures. The use of denosumab can significantly reduce the risk of fractures, particularly of the spine and hip. This is particularly beneficial for older adults and menopausal women, who are more at risk from these types of fractures.

Denosumab is also used in certain cancer patients, especially those with painful bone metastases. It can slow or reduce the progression of bone metastases, thereby relieving bone pain and improving patients' quality of life. Desosumab may also be used for the prevention of osteoporosis, particularly in high-risk groups such as menopausal women and patients on long-term glucocorticoid use. It can help maintain bone density and reduce the risk of future fractures.